First analysis of immune cell infiltration in stage pT1 urothelial bladder carcinoma: CD3 positivity as a prognostic marker for cancer-specific survival

World Journal of Urology

Volumn 30, Issue 6, 2012, Pages 875-877

  Otto, Wolfgang ^a   Denzinger, Stefan ^a   Wieland, Wolf F ^a   Hartmann, Arndt ^b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN;

BLADDER TUMOR; CANCER STAGING; CELL MOTION; CYSTECTOMY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; IMMUNOLOGY; KAPLAN MEIER METHOD; LETTER; MALE; METABOLISM; MORTALITY; PATHOLOGY; PROGNOSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; T LYMPHOCYTE; TRANSITIONAL CELL CARCINOMA; UROTHELIUM;

ANTIGENS, CD3; CARCINOMA, TRANSITIONAL CELL; CELL MOVEMENT; CYSTECTOMY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; NEOPLASM STAGING; PROGNOSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; T-LYMPHOCYTES; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 84870361829     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-012-0974-2     Document Type: Letter

References (5)

1. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pagès C, Tosolini M, Camus M, Berger A, Wind P, Zinzindohoué F, Bruneval P et al (2006) Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313(5795): 1960-1964.
2. Fridman WH, Galon J, Pagès F, Tartour E, Sautès-Fridman C, Kroemer G (2011) Prognostic and predictive impact of intra- and peritumoral immune infiltrates. Cancer Res 71(17): 5601-5605.
3. Hilmy M, Campbell R, Bartlett JM, McNicol AM, Underwood MA, McMillan DC (2006) The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic infiltration and COX-2 expression and survival in patients with transitional cell carcinoma of the urinary bladder. Br J Cancer 95(9): 1234-1238.
4. Winerdal ME, Marits P, Winerdal M, Hasan M, Rosenblatt R, Tolf A, Selling K, Sherif A, Winqvist O (2011) FOXP3 and survival in urinary bladder cancer. BJU Int 108(10): 1672-1678.
5. van den Bosch S, Alfred Witjes J (2011) Long-term cancer-specific survival in patients with high-risk, non-muscle-invasive bladder cancer and tumour progression: a systematic review. Eur Urol 60(3): 493-500.